glp-1 induced gastroparesis Understanding receptor agonists and their impact on drug discovery Ozempic and Gastroparesis: Do GLP-1

Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro

Slow down how quickly food leaves your stomach, helping you feel full longer

An investigation into N-terminally constrained analogues of glucagon-like peptide 1 (GLP-1) and exendin-4

If youre interested in improving your metabolic health, take the quiz to find out if youre eligible for the Calibrate Metabolic Reset

Versions for printing (in English, te reo Mori, Samoan and Tongan) Acknowledgements The content on this page has been developed and approved by the Clinical Network for Children and Young People with Diabetes, Paediatric Society of New Zealand | Te Khui Mtai Arotamariki o Aotearoa.

A further drive to utilise GLP-1 RAs arises from the cardiorenal benefits offered with some of the therapies